213 related articles for article (PubMed ID: 29198770)
1. Preoperative enteral access is not necessary prior to multimodality treatment of esophageal cancer.
Jenkins TK; Lopez AN; Sarosi GA; Ben-David K; Thomas RM
Surgery; 2018 Apr; 163(4):770-776. PubMed ID: 29198770
[TBL] [Abstract][Full Text] [Related]
2. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review.
Huddy JR; Huddy FMS; Markar SR; Tucker O
Dis Esophagus; 2018 Jan; 31(1):1-11. PubMed ID: 29024949
[TBL] [Abstract][Full Text] [Related]
3. Pre-therapy laparoscopic feeding jejunostomy is safe and effective in patients undergoing minimally invasive esophagectomy for cancer.
Ben-David K; Kim T; Caban AM; Rossidis G; Rodriguez SS; Hochwald SN
J Gastrointest Surg; 2013 Aug; 17(8):1352-8. PubMed ID: 23709367
[TBL] [Abstract][Full Text] [Related]
4. Nutritional support with endoluminal stenting during neoadjuvant therapy for esophageal malignancy.
Bower M; Jones W; Vessels B; Scoggins C; Martin R
Ann Surg Oncol; 2009 Nov; 16(11):3161-8. PubMed ID: 19636630
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
Tiesi G; Park W; Gunder M; Rubio G; Berger M; Ardalan B; Livingstone A; Franceschi D
J Surg Res; 2017 Aug; 216():65-72. PubMed ID: 28807215
[TBL] [Abstract][Full Text] [Related]
6. Reassessment of the role of enteral tube feedings for patients with esophageal cancer.
Starr B; Davis S; Ayala-Peacock D; Blackstock WA; Levine EA
Am Surg; 2014 Aug; 80(8):752-8. PubMed ID: 25105392
[TBL] [Abstract][Full Text] [Related]
7. Self-expanding plastic esophageal stents versus jejunostomy tubes for the maintenance of nutrition during neoadjuvant chemoradiation therapy in patients with esophageal cancer: a retrospective study.
Siddiqui AA; Glynn C; Loren D; Kowalski T
Dis Esophagus; 2009; 22(3):216-22. PubMed ID: 19207544
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes of resected esophageal cancer.
Hofstetter W; Swisher SG; Correa AM; Hess K; Putnam JB; Ajani JA; Dolormente M; Francisco R; Komaki RR; Lara A; Martin F; Rice DC; Sarabia AJ; Smythe WR; Vaporciyan AA; Walsh GL; Roth JA
Ann Surg; 2002 Sep; 236(3):376-84; discussion 384-5. PubMed ID: 12192324
[TBL] [Abstract][Full Text] [Related]
10. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
[TBL] [Abstract][Full Text] [Related]
11. Treatment of clinical T2N0M0 esophageal cancer.
Hardacker TJ; Ceppa D; Okereke I; Rieger KM; Jalal SI; LeBlanc JK; DeWitt JM; Kesler KA; Birdas TJ
Ann Surg Oncol; 2014 Nov; 21(12):3739-43. PubMed ID: 25047477
[TBL] [Abstract][Full Text] [Related]
12. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.
Vermund H; Pories WJ; Hillard J; Wiley AL; Youngblood R
Acta Oncol; 2001; 40(5):558-65. PubMed ID: 11669326
[TBL] [Abstract][Full Text] [Related]
14. Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.
Ruol A; Portale G; Castoro C; Merigliano S; Cagol M; Cavallin F; Chiarion Sileni V; Corti L; Rampado S; Costantini M; Ancona E
Ann Surg Oncol; 2007 Nov; 14(11):3243-50. PubMed ID: 17713823
[TBL] [Abstract][Full Text] [Related]
15. Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.
Koëter M; van der Sangen MJ; Hurkmans CW; Luyer MD; Rutten HJ; Nieuwenhuijzen GA
Radiat Oncol; 2015 Mar; 10():59. PubMed ID: 25884226
[TBL] [Abstract][Full Text] [Related]
16. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
[TBL] [Abstract][Full Text] [Related]
17. Curative treatment for esophageal cancer: Vancouver Island Cancer Centre experience from 1993 to 1998.
Wilson KS; Wilson AG; Dewar GJ
Can J Gastroenterol; 2002 Jun; 16(6):361-8. PubMed ID: 12096299
[TBL] [Abstract][Full Text] [Related]
18. Is MIB-1 proliferation index a predictor for response to neoadjuvant therapy in patients with esophageal cancer?
Imdahl A; Jenkner J; Ihling C; Rückauer K; Farthmann EH
Am J Surg; 2000 Jun; 179(6):514-20. PubMed ID: 11004343
[TBL] [Abstract][Full Text] [Related]
19. Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy.
Huerter ME; Charles EJ; Downs EA; Hu Y; Lau CL; Isbell JM; McMurry TL; Kozower BD
Ann Thorac Surg; 2016 Sep; 102(3):948-954. PubMed ID: 27209608
[TBL] [Abstract][Full Text] [Related]
20. Single-institution retrospective comparison of preoperative versus definitive chemoradiotherapy for adenocarcinoma of the esophagus.
Shridhar R; Freilich J; Hoffe SE; Almhanna K; Fulp WJ; Yue B; Karl RC; Meredith K
Ann Surg Oncol; 2014 Nov; 21(12):3744-50. PubMed ID: 24854492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]